Previously treated cases tested for RR-/MDR-TB in Sweden
Sweden: Previously treated cases tested for RR-/MDR-TB was 50.0% in 2024. ▼ Falling
Previously treated cases tested for RR-/MDR-TB in Sweden, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, previously treated cases tested for rr-/mdr-tb in Sweden stood at 50.0%.
Compared with earlier readings it is up 8.7% on the previous year and down 5.7% over ten years.
Over the whole period, previously treated cases tested for rr-/mdr-tb in Sweden peaked at 100.0% in 2006 and was at its lowest, 0.0%, in 2019.
That places Sweden 150th out of 180 countries with data for 2024, putting it in the bottom quarter.
The long-run direction has been consistently falling across the 20 years of available data.
Previously treated cases tested for RR-/MDR-TB in Sweden, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 57.0% | — |
| 2006 | 100.0% | +75.4% |
| 2007 | 59.0% | -41.0% |
| 2008 | 81.0% | +37.3% |
| 2009 | 76.0% | -6.2% |
| 2010 | 58.0% | -23.7% |
| 2011 | 69.0% | +19.0% |
| 2012 | 62.0% | -10.1% |
| 2013 | 60.0% | -3.2% |
| 2014 | 53.0% | -11.7% |
| 2015 | 62.0% | +17.0% |
| 2016 | 100.0% | +61.3% |
| 2017 | 81.0% | -19.0% |
| 2018 | 85.0% | +4.9% |
| 2019 | 0.0% | -100.0% |
| 2020 | 83.0% | — |
| 2021 | 100.0% | +20.5% |
| 2022 | 76.0% | -24.0% |
| 2023 | 46.0% | -39.5% |
| 2024 | 50.0% | +8.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 74.6% | 57.0% | 100.0% | 5 |
| 2010s | 63.0% | 0.0% | 100.0% | 10 |
| 2020s | 71.0% | 46.0% | 100.0% | 5 |
Countries ranked near Sweden
More health data for Sweden
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.8581 % change on previous year (2090)
- Heat deaths vs projected death rates 1,109 (2090)
- Un projection of annual infant deaths 30 (2100)
- Population ages 65 and above, female, annual growth rate 0.9511 % change on previous year (2025)
- Population ages 65 and above, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, female, per capita 0.111 units per person (2025)
- Population ages 65 and above, male, annual growth rate 1.18 % change on previous year (2025)
- Population ages 65 and above, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, male, per capita 0.0981 units per person (2025)
Frequently asked questions
- What is previously treated cases tested for rr-/mdr-tb in Sweden?
- Previously treated cases tested for rr-/mdr-tb in Sweden was 50.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest previously treated cases tested for rr-/mdr-tb recorded in Sweden?
- The highest recorded value was 100.0% in 2006.
- What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Sweden?
- The lowest recorded value was 0.0% in 2019.
- How does Sweden rank for previously treated cases tested for rr-/mdr-tb?
- Sweden ranks 150th out of 180 countries with data for 2024.
- Is previously treated cases tested for rr-/mdr-tb rising or falling in Sweden?
- Over the last ten years it is down 5.7%. The long-run trend across the full record is falling.
- Where does this Sweden data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).